Parkinson's Disease Trial, Recruiting NCT07700862 Sponsor: Ruijin Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07700862
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (the most common form of Parkinson's, with no known cause)
  • People whose main Parkinson's symptom is tremor (shaking), measured when they have not taken their Parkinson's medication
  • People whose Parkinson's disease falls within a certain range of severity (stages 2 to 4 on a standard medical scale called the modified Hoehn-Yahr scale), measured when they have not taken their Parkinson's medication
  • People who have been regularly taking Parkinson's medication for more than 6 weeks
  • People who are willing and able to follow the trial requirements and who have provided written consent to participate

Who may not be able to join:

  • People who have an atypical form of parkinsonism (a Parkinson's-like condition with a different underlying cause)
  • People with a history of stroke, brain infection, or use of certain psychiatric medications, or whose brain scan shows significant changes such as brain shrinkage, small areas of damage, or other findings that could affect the safety of brain surgery
  • People who have cognitive difficulties, psychiatric conditions, or other health conditions (such as dementia, epilepsy, a history of serious head injury, brain tumour, schizophrenia, severe depression, bipolar disorder, or personality disorder) that could affect their ability to complete assessments or give informed consent
  • People who have abnormal anatomy in the area of the brain being targeted in this trial
  • People with a significant medical history that could increase the risk of complications before or after surgery
  • People with any other condition that the trial investigators believe could interfere with the surgery, follow-up visits, or the accuracy of the trial results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +0086-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change from Baseline in Movement Disorder Society-sponsord Unified Parkinson's Disease Rating Scale Part III tremor subscore Between PSA and STN Stimulation in the chronic randomized phase

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov